Changes and advances in the field of infective endocarditis

Br J Hosp Med (Lond). 2022 Mar 2;83(3):1-11. doi: 10.12968/hmed.2021.0510. Epub 2022 Mar 17.

Abstract

Infective endocarditis is a rare but deadly disease, with a highly variable presentation. The clinical manifestations of the condition are often multisystemic, ranging from dermatological to ophthalmic, and cardiovascular to renal. Thus, patients with infective endocarditis may first present to the acute or general physician, who may have a variable knowledge of the condition. The diagnosis of infective endocarditis can be challenging, relying on clinical, imaging and microbiological features. Recent decades have seen a transformation in the epidemiology and microbiology of infective endocarditis and yet, despite advances in diagnostics and therapeutics, mortality rates remain high. This review outlines the emerging studies and guidelines on the assessment and management of infective endocarditis, focusing on the evolving epidemiology of the condition, the role of new imaging modalities, updated diagnostic criteria, the latest on antimicrobial and surgical management, and the role of a multidisciplinary approach in the management of patients with infective endocarditis.

Keywords: Echocardiography; Embolism; Heart failure; Infection; Infective endocarditis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents*
  • Endocarditis* / diagnosis
  • Endocarditis* / epidemiology
  • Endocarditis* / therapy
  • Endocarditis, Bacterial* / diagnosis
  • Endocarditis, Bacterial* / epidemiology
  • Endocarditis, Bacterial* / therapy
  • Heart
  • Humans

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents